Nuveen Asset Management, LLC Chembio Diagnostics, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $167,927 - $328,857	-58,308 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $16,877 - $39,563	-4,964 Reduced 7.85%	58,308 $204,000
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $449,120 - $820,655	-109,275 Reduced 63.33%	63,272 $300,000
Q3 2020 Nov 16, 2020	BUY	$3.28 - $5.93 $204,458 - $369,646	62,335 Added 56.56%	172,547 $839,000
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $350,474 - $1.71 Million	110,212 New	110,212 $358,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.